122
Views
0
CrossRef citations to date
0
Altmetric
Review

Scintigraphic parathyroid imaging: concepts and new developments

, &
Pages 9-18 | Published online: 22 Jun 2015

References

  • Carney JA. The glandulaeparathyroideae of Ivar Sandstrom. Contributions from two continents. Am J Surg Pathol. 1996;20:1123–1144.
  • Kettle AG, O’Doherty M. Parathyroid imaging: how good is it and how should it be done? Semin Nucl Med. 2006;36:206–211.
  • Uldelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235(5):665–672.
  • Elgazzar AH. Parathyroid gland. In: The Pathophysiologic Basis of Nuclear Medicine. 2nd ed. New York, NY: Springer; 2006:222–237.
  • Kunstman JW, Kirsch JD, Mahajan A, Udelsman R. Clinical review: parathyroid localization and implications for clinical management. J Clin Endocrinol Metab. 2013;98:902–912.
  • Akerstrom G, Grimelius L, Johansson H, Lundquist H, Pertoft H, Bergstrom R. The parenchymal cell mass in normal human parathyroid glands. Acta Pathol Microbiol Immunol Scand. 1981;89(A):367.
  • Maxon HR, Elgazzar AH. Parathyroid imaging. In: Gelfand G, Thomas S, editors. Effective Use of Computers in Nuclear Medicine. New York, NY: McGraw Hill; 1988:485–496.
  • Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery. 1984;95:15–21.
  • Wang CA. The anatomic basis of parathyroid surgery. Ann Surg. 1976;183:271–275.
  • Zerizer I, Parsai A, Win Z, Al-Nahhas A. Anatomical and functional localization of ectopic parathyroid adenomas: 6-year institutional experience. Nucl Med Commun. 2011;32:496–502.
  • Ritter CS, Haughey BH, Miller B, Brown A. Differential gene expression by oxyphil and chief cells of human parathyroid glands. J Clin Endocrinol Metab. 2012;97:E1499–E1505.
  • Palestro C, Tomas M, Tronco G. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005;35:266–276.
  • Walker RP, Paloyan E, Gopalsami C. Symptoms in patients with primary hyperparathyroidism: muscle weakness or sleepiness. Endocr Pract. 2004;10:404–408.
  • Skogseid B, Rastad J, Oberg K. Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am. 1994;23:1–17.
  • Heath H III. Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Miner Res. 1991;6:S63–S70.
  • Sy WM, Mittal AK. Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy. Br J Radiol. 1975;48:878–884.
  • Thompson NW, Eckhauser FE, Harness JK. The anatomy of primary hyperparathyroidism. Surgery. 1982;92:814–821.
  • Simeone DM, Sandelin K, Thompson NW. Undescended superior parathyroid gland: a potential cause of failed cervical exploration for hyperparathyroidism. Surgery. 1995;118:949–956.
  • Shen W, Duren M, Morita E, et al. Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg. 1996;131:861–869.
  • Doppman JL, Skarulis MC, Chen CC, et al. Parathyroid adenomas in the aortopulmonary window. Radiology. 1996;201:456–462.
  • Fleischer J, Becker C, Hamele-Bena D, et al. Oxyphil parathyroid adenoma: a malignant presentation of a benign disease. J Clin Endocrinol Metab. 2004;89:5948–5951.
  • Tezelman S, Shen W, Shaver JK, et al. Double parathyroid adenomas: clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg. 1993;218:300–309.
  • Akerstrom G, Rastad J, Ljunghall S, Johnsson H. Clinical and experimental advances in sporadic primary hyperparathyroidism. Acta Chir Scand. 1990;156:23–28.
  • Cook M, Qureshi Y, Todd C, Cummins R. An unusual ectopic location of a parathyroid carcinoma arising within the thyroid gland. J Clin Endocrinol Metab. 2012;97:1829–1833.
  • Lack CA, Rarber JL, Rubin E. The endocrine system. In: Rubin E, Farber JL, editors. Pathology. 3rd ed. Philadelphia, PA: Lippincott-Raven; 1999:1179–1183.
  • Bleier B, LiVolsi V, Chalian A, et al. Technetium Tc 99m sestamibi sensitivity in oxyohil cell-dominant parathyroid adenomas. Arch Otolaryngol Head Neck Surg. 2006;132:779–782.
  • Wang CA. Parathyroid re-exploration: a clinical and pathological study of 112 cases. Ann Surg. 1977;186:140.
  • Assalia A, Inabnet WB. Endoscopic parathyroidectomy. Otolaryngol Clin North Am. 2004;37:871–886.
  • Thomas SK, Wishart GC. Trends in surgical techniques. Nucl Med Commun. 2003;24:115–119.
  • Erdman WA, Breslau NA, Weinreb JC, et al. Noninvasive localization of parathyroid adenomas: a comparison of X-ray computerized tomography, ultrasound, scintigraphy and MRI. Magn Reson Imaging. 1989;7:187–194.
  • Auffermann W, Gooding GA, Okerlund MD, et al. Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniques. AJR Am J Roentgenol. 1988;150:1027–1033.
  • Peck WW, Higgins CR, Fisher MR, Ling M, Okerland MD, Clark OH. Hyperparathyroidism: comparison of MR imaging with radionuclide scanning. Radiology. 1987;163:415–420.
  • Levin KE, Gooding GA, Okerlund M, et al. Localizing studies in patients with persistent or recurrent hyperparathyroidism. Surgery. 1987;102:917–925.
  • Miller DL, Doppman JR, Shawker TH, et al. Localization of parathyroid adenomas in patients who have undergone surgery. Part I. Noninvasive imaging methods. Radiology. 1987;162:133–137.
  • Ferlin G, Borsato N, Camerani M, Conte N, Zotti D. New perspective in localizing enlarged parathyroids by technetium-thallium subtraction scan. J Nucl Med. 1983;24:438–441.
  • Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with Tc-99m sestamibi (double phase study). J Nucl Med. 1992;33:1801–1807.
  • Nichols K, Tomas M, Tronoco G, Palestro C. Sestamibi parathyroid scintigraphy in multigland disease. Nucl Med Commun. 2012;33(1):43–50.
  • Neumann DR, Esselstyn CB, MacIntyre WJ, et al. Comparison of FDG-PET and sestamibi SPECT in primary hyperparathyroidism. J Nucl Med. 1996;37:1809–1815.
  • Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med. 1995;22:556–558.
  • Sundin A, Johansson C, Hellman P, et al. PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med. 1996;37:1766–1770.
  • Beggs AD, Hain SF. Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl Med Commun. 2005;26:133–136.
  • Weber T, Maier-Funk C, Ohlhauser D, et al. Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg. 2013;257:1124–1128.
  • Quak E, Lheureux S, Renzik Y, Bardet S, Aide N. F18-choline, a novel tracer for parathyroid adenoma? J Clin Endocrinol Metab. 2013;98(8):3111–3112.
  • O’Doherty MJ, Kettle AG, Wells P, Collins RE, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33(3):313–318.
  • Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977–984.
  • Mitchell BK, Merrell RC, Kinder BK. Localization studies in patients with hyperparathyroidism. Endocr Surg. 1995;75:483–498.
  • Akerstrom G, Rudberg C, Grimelius L, et al. Histologic parathyroid abnormalities in an autopsy series. Hum Pathol. 1986;17:520–527.
  • Klieger P, O’Mara R. The diagnostic utility of dual phase Tc-99m sestamibi parathyroid imaging. Clin Nucl Med. 1998;23:208–211.
  • Goris ML, Basso LV, Keeling C. Parathyroid imaging. J Nucl Med. 1991;32:887–889.
  • Elgazzar AH, Maxon HR, Hertzberg V, et al. Parathyroid scintigraphy with and without thyroid hormone suppression. Proceedings of the Eastern Great Lakes Chapter, Society of Nuclear Medicine, Niagara Falls, NY, 1985.
  • Bonjer HJ, Bruining HA, Valkema R, et al. Single radionuclide scintigraphy with 99m-technetium-sestamibi and ultrasonography in hyperparathyroidism. Eur J Surg. 1997;163:27–32.
  • De Feo ML, Colagrande S, Biagini C, et al. Parathyroid glands: combination of 99mTc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology. 2000;214:393–402.
  • Mazzeo S, Caramella D, Lencioni R, et al. Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. AJR Am J Roentgenol. 1996;166:1465–1470.
  • Slater A, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection. Clin Nucl Med. 2005;30:1–3.
  • Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperthyroidism. Surgery. 2002;131:149–157.
  • Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19:577–583.
  • Takebayashi S, Hidai H, Chiba T, Takaga Y, Nagatani Y, Matsubara S. Hyperfunctional parathyroid glands with Tc-99m MIBI scan: semiquantitaive analysis correlated with histologic findings. J Nucl Med. 1999;40:1792–1797.
  • Carpentier A, Jeannotte S, Verrault J, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI and oxyphil cell count. J Nucl Med. 1998;39:1441–1444.
  • Sandrock D, Merino MJ, Norton JA, Neumann RD. Ultrastructural histology correlates with results of Thallium-201/Tc-99m parathyroid subtraction scintigraphy. J Nucl Med. 1993;34:24–29.
  • Kao A, Shiau YC, Tsai SC, Wang JJ, Ho ST. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med Mol Imaging. 2002;29:1012–1015.
  • Mehta N, Ruda J, Kapadia S, Boyer P, Hollenbeak C, Stack B. Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue. Arch Otolaryngol Head Neck Surg. 2005;131:493–498.
  • Lee VS, Wilkinson RH, Leight GS, Coogan AC, Coleman RE. Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging. Radiology. 1995;197:627–633.
  • McHenry CR, Lee K, Saadey J, et al. Parathyroid localization with technetium-99m-sestamibi: a prospective evaluation. J Am Coll Surg. 1996;183:25–30.
  • Elgazzar A, Alenezi S.. Parathyroid gland. In: Elgazzar A, editor. Pathophysiologic Basis of Nuclear Medicine. 3rd ed. Berlin, Germany: Springer; 2014.